2.25

5.06% -0.12

After Hours: 2.25

Maravai Lifesciences Holdings Inc (MRVI)

Overview News Price History Option Chain Financials Why MRVI Down? Discussions Forecast

Maravai Lifesciences Holdings Inc stock is traded at $2.25, with a volume of 3.24M. It is down -5.06% in the last 24 hours and up +8.70% over the past month. Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Previous Close:

$2.37

Open:

$2.34

24h Volume:

3.24M

Relative Volume:

1.20

Market Cap:

$323.96M

Revenue:

$288.95M

Net Income/Loss:

$-119.03M

P/E Ratio:

-2.4986

EPS:

-0.9005

Net Cash Flow:

$60.67M

1W Performance:

+1.35%

1M Performance:

+8.70%

6M Performance:

-60.32%

1Y Performance:

-74.69%

1-Day Range:

$2.22

$2.35

1-Week Range:

$2.195

$2.41

52-Week Range:

$1.665

$10.03

Maravai Lifesciences Holdings Inc Stock (MRVI) Company Profile

Name

Maravai Lifesciences Holdings Inc

Sector

Healthcare (1170)

Industry

Biotechnology (667)

Phone

(858) 546-0004

Address

10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO

Employee

580

Twitter

Next Earnings Date

2025-03-18

Latest SEC Filings

MRVI's Discussions on Twitter

Compare MRVI with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MRVI Maravai Lifesciences Holdings Inc	2.25	319.63M	288.95M	-119.03M	60.67M	-0.9005
ONC Beone Medicines Ltd Adr	245.58	26.10B	3.81B	-644.79M	-669.77M	-6.24
VRTX Vertex Pharmaceuticals Inc	442.05	111.96B	11.10B	-988.90M	-1.26B	-3.92
AKTX Akari Therapeutics Plc Adr	1.35	42.96M	0	0	0	0.00
VRNA Verona Pharma Plc Adr	81.20	6.39B	0	-153.72M	-103.81M	-2.00
REGN Regeneron Pharmaceuticals Inc	490.28	63.52B	14.09B	4.50B	2.96B	39.28

Maravai Lifesciences Holdings Inc Stock (MRVI) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-26-25	Downgrade	Robert W. Baird	Outperform → Neutral
Dec-19-24	Initiated	Guggenheim	Neutral
Dec-05-24	Downgrade	Goldman	Neutral → Sell
Nov-14-24	Initiated	Wolfe Research	Peer Perform
Nov-08-24	Downgrade	William Blair	Outperform → Mkt Perform
Aug-28-24	Initiated	Wells Fargo	Overweight
Aug-13-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Apr-10-24	Initiated	Craig Hallum	Buy
Dec-12-23	Upgrade	BofA Securities	Neutral → Buy
Aug-08-23	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
May-23-23	Downgrade	Credit Suisse	Outperform → Neutral
May-09-23	Downgrade	Goldman	Buy → Neutral
Jan-05-23	Downgrade	UBS	Buy → Neutral
Dec-14-22	Initiated	Deutsche Bank	Buy
Dec-07-22	Initiated	RBC Capital Mkts	Outperform
Nov-03-22	Downgrade	BofA Securities	Buy → Neutral
Aug-25-22	Initiated	Credit Suisse	Outperform
Aug-05-21	Resumed	Credit Suisse	Outperform
Dec-16-20	Initiated	KeyBanc Capital Markets	Overweight
Dec-15-20	Initiated	BofA Securities	Buy
Dec-15-20	Initiated	Credit Suisse	Outperform
Dec-15-20	Initiated	Goldman	Buy
Dec-15-20	Initiated	Jefferies	Buy
Dec-15-20	Initiated	Robert W. Baird	Outperform
Dec-15-20	Initiated	Stifel	Buy
Dec-15-20	Initiated	William Blair	Outperform
Dec-14-20	Initiated	UBS	Buy

View All

Maravai Lifesciences Holdings Inc Stock (MRVI) Latest News

May 30, 2025

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Stock Holdings Cut by Bank of America Corp DE - Defense World

May 30, 2025

ProShare Advisors LLC Raises Stock Holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World

May 30, 2025

May 29, 2025

Maravai LifeSciences Announces Shareholder Meeting Results - Investing.com Australia

May 29, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire

May 29, 2025

Maravai LifeSciences Sees Unusually Large Options Volume (NASDAQ:MRVI) - Defense World

May 29, 2025

May 28, 2025

Maravai Lifesciences Holds Annual Shareholders Meeting - TipRanks

May 28, 2025

Maravai LifeSciences Announces Shareholder Meeting Results By Investing.com - Investing.com Nigeria

May 28, 2025

May 27, 2025

BNP Paribas Financial Markets Purchases Shares of 66,443 Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World

May 27, 2025

May 22, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Stockholders to Inquire about Securities Investigation - ACCESS Newswire

May 22, 2025

May 21, 2025

CORRECTION -- Maravai LifeSciences Releases 2024 Sustainability Report | MRVI Stock News - GuruFocus

May 21, 2025

Maravai LifeSciences Releases 2024 Sustainability Report Highlighting Product Innovation, Governance Enhancements, and Commitment to Sustainable Growth - Nasdaq

May 21, 2025

CORRECTION – Maravai LifeSciences Releases 2024 Sustainability Report - GlobeNewswire

May 21, 2025

Maravai Sustainability Report: 10x Manufacturing Expansion Plus Major Green Energy Milestones - Stock Titan

May 21, 2025

Maravai LifeSciences Releases 2024 Sustainability Report - GlobeNewswire

May 21, 2025

Maravai LifeSciences Sustainability Report: 49 New Products and 10X GMP Manufacturing Expansion Drive Growth - Stock Titan

May 21, 2025

Northern Trust Corp Buys 53,474 Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World

May 21, 2025

May 20, 2025

Revolutionary mRNA Synthesis Kit Achieves 2X Yield, 85% Lower dsRNA: TriLink's Game-Changing Launch - Stock Titan

May 20, 2025

May 16, 2025

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Consensus Recommendation of “Hold” by Brokerages - Defense World

May 16, 2025

May 15, 2025

Maravai LifeSciences Q1 2025 Earnings Call: Growth Amid Challenges - TipRanks

May 15, 2025

Price T Rowe Associates Inc. MD Acquires 7,946 Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World

May 15, 2025

Robert W. Baird Has Lowered Expectations for Maravai LifeSciences (NASDAQ:MRVI) Stock Price - Defense World

May 15, 2025

Stock Traders Buy Large Volume of Put Options on Maravai LifeSciences (NASDAQ:MRVI) - Defense World

May 15, 2025

May 14, 2025

TriLink BioTechnologies® and the International Vaccine Institute Sign a Memorandum of Understanding to Support the Development of mRNA-based Vaccines - marketscreener.com

May 14, 2025